Effectiveness of Dry Needling in Shortened Triceps Surae Muscle

Effectiveness of Deep Dry Needling in Subjects With Shortened Triceps Surae Originated by Myofascial Pain Syndrome

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03273985

Acronym

DN-TS

Enrollment

Registered

2017-09-06

Start date

2017-09-15

Completion date

2017-12-06

Last updated

2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Point Pain, Myofascial, Myofascial Pain Syndrome

Brief summary

To date, there are not studies about the effectiveness of dry needling versus ischemic compression in the triceps surae trigger points. A randomized clinical trial is carried out. A sample of 30 subjects are recruited and allocated into dry needling (n = 15) and ischemic compression (n = 15). Outcome measurements such as dorsal flexion range of motion, plantar pressures, temperature, superficial muscle activity and trigger points pressure pain threshold are measured immediately before and after treatment.

Interventions

OTHERDry needling

Trigger point deep dry needling

OTHERIschemic compression

Trigger point ischemic compression

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Myofascial pain syndrome in the triceps surae muscle, limitation of ankle dorsal flexion range of motion.

Exclusion criteria

* Neurologic disorders, pharmacologic treatment (within the previous 3 months), cognitive impairment, prosthesis in the lower limb, systemic or infectious diseases, autoimmune diseases, fibromyalgia, hypothyroidism, anticoagulants or antiplatelet agents, and fear of needles.

Design outcomes

Primary

Measure	Time frame	Description
Range of motion	Change from Baseline Range of motion at 25 minutes	Ankle dorsal flexion by means of the goniometer

Secondary

Measure	Time frame	Description
Plantar pressures	Change from Baseline Plantar pressures at 25 minutes	Plantar pressures platform
Temperature	Change from Baseline Temperature at 25 minutes	Thermal imaging
Superficial muscle activity	Change from Baseline Superficial muscle activity at 25 minutes	Electromyography
Pressure pain threshold	Change from Baseline Pressure pain threshold at 25 minutes	Algometer

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026